These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 23927080

  • 21. Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant.
    Lazic R, Lukic M, Boras I, Draca N, Vlasic M, Gabric N, Tomic Z.
    Retina; 2014 Apr; 34(4):719-24. PubMed ID: 23975006
    [Abstract] [Full Text] [Related]

  • 22. The area of fixation covaries with short-term changes in visual acuity after anti-vascular endothelial growth factor treatment in patients with diabetic macular oedema.
    Jakobsen NS, Larsen DA, Bek T.
    Acta Ophthalmol; 2018 Nov; 96(7):744-748. PubMed ID: 29687595
    [Abstract] [Full Text] [Related]

  • 23. Prospective study of aflibercept for the treatment of persistent macular oedema secondary to retinal vein occlusions in eyes not responsive to long-term treatment with bevacizumab or ranibizumab.
    Spooner K, Fraser-Bell S, Hong T, Chang A.
    Clin Exp Ophthalmol; 2020 Jan; 48(1):53-60. PubMed ID: 31498950
    [Abstract] [Full Text] [Related]

  • 24. Improvement of diabetic retinopathy with intravitreal Ranibizumab.
    Kernt M, Cserhati S, Seidensticker F, Liegl R, Kampik A, Neubauer A, Ulbig MW, Reznicek L.
    Diabetes Res Clin Pract; 2013 Apr; 100(1):e11-3. PubMed ID: 23391744
    [Abstract] [Full Text] [Related]

  • 25. Influence of Glycosylated Hemoglobin on the Efficacy of Ranibizumab for Diabetic Macular Edema: A Post Hoc Analysis of the RIDE/RISE Trials.
    Bansal AS, Khurana RN, Wieland MR, Wang PW, Van Everen SA, Tuomi L.
    Ophthalmology; 2015 Aug; 122(8):1573-9. PubMed ID: 26050541
    [Abstract] [Full Text] [Related]

  • 26. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
    Maturi RK, Bleau L, Saunders J, Mubasher M, Stewart MW.
    Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
    [Abstract] [Full Text] [Related]

  • 27. Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison.
    Gado AS, Macky TA.
    Clin Exp Ophthalmol; 2014 Aug; 42(7):650-5. PubMed ID: 24612095
    [Abstract] [Full Text] [Related]

  • 28. Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity.
    Busch C, Okada M, Zur D, Fraser-Bell S, Rodríguez-Valdés PJ, Cebeci Z, Lupidi M, Fung AT, Gabrielle PH, Giancipoli E, Chaikitmongkol V, Laíns I, Santos AR, Kunavisarut P, Sala-Puigdollers A, Chhablani J, Ozimek M, Hilely A, Degenhardt V, Loewenstein A, Iglicki M, Rehak M, International Retina Group.
    Acta Ophthalmol; 2020 Nov; 98(7):e801-e806. PubMed ID: 32115886
    [Abstract] [Full Text] [Related]

  • 29. Antivascular endothelial growth factors in the treatment of macular oedema secondary to central retinal vein occlusion: a meta-analysis.
    Zhou S, Gao J, Xu X.
    Clin Exp Ophthalmol; 2014 Nov; 42(7):637-49. PubMed ID: 24330277
    [Abstract] [Full Text] [Related]

  • 30. Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study.
    Isaac DL, Abud MB, Frantz KA, Rassi AR, Avila M.
    Acta Ophthalmol; 2012 Feb; 90(1):56-60. PubMed ID: 20015098
    [Abstract] [Full Text] [Related]

  • 31. Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration.
    Nischler C, Oberkofler H, Ortner C, Paikl D, Riha W, Lang N, Patsch W, Egger SF.
    Acta Ophthalmol; 2011 Jun; 89(4):e344-9. PubMed ID: 21232084
    [Abstract] [Full Text] [Related]

  • 32. Intravitreal ranibizumab for diabetic macular oedema: 1-year experiences in a clinical setting.
    Brynskov T, Laugesen CS, Sørensen TL.
    Acta Ophthalmol; 2013 May; 91(3):e243-4. PubMed ID: 23280048
    [No Abstract] [Full Text] [Related]

  • 33. Efficacy of intravitreal anti-vascular endothelial growth factor or steroid injection in diabetic macular edema according to fluid turbidity in optical coherence tomography.
    Lee K, Chung H, Park Y, Sohn J.
    Korean J Ophthalmol; 2014 Aug; 28(4):298-305. PubMed ID: 25120338
    [Abstract] [Full Text] [Related]

  • 34. Variants in the VEGFA gene and treatment outcome after anti-VEGF treatment for neovascular age-related macular degeneration.
    Abedi F, Wickremasinghe S, Richardson AJ, Makalic E, Schmidt DF, Sandhu SS, Baird PN, Guymer RH.
    Ophthalmology; 2013 Jan; 120(1):115-21. PubMed ID: 23149126
    [Abstract] [Full Text] [Related]

  • 35. Effect of intravitreal triamcinolone in diabetic macular edema unresponsive to intravitreal bevacizumab.
    Jeon S, Lee WK.
    Retina; 2014 Aug; 34(8):1606-11. PubMed ID: 24553409
    [Abstract] [Full Text] [Related]

  • 36. Acute visual acuity loss following intravitreal bevacizumab for diabetic macular edema.
    Chen E, Hsu J, Park CH.
    Ophthalmic Surg Lasers Imaging; 2009 Aug; 40(1):68-70. PubMed ID: 19205502
    [Abstract] [Full Text] [Related]

  • 37. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).
    Paccola L, Costa RA, Folgosa MS, Barbosa JC, Scott IU, Jorge R.
    Br J Ophthalmol; 2008 Jan; 92(1):76-80. PubMed ID: 17965109
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. PROSPECTIVE RANDOMIZED SUBJECT-MASKED STUDY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY VERSUS DEXAMETHASONE IMPLANT MONOTHERAPY IN THE TREATMENT OF PERSISTENT DIABETIC MACULAR EDEMA.
    Shah SU, Harless A, Bleau L, Maturi RK.
    Retina; 2016 Oct; 36(10):1986-96. PubMed ID: 27124881
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.